Ардзинба Мераб Сергеевич

New possibilities in the treatment of EGFR mutation-positive non-small-cell lung cancer patients after the progression on a 1st and 2nd generation EGFR tyrosine kinase inhibitors

I. Demidova, A. R. Zaretsky, K. Laktionov, 2018, Journal of Modern Oncology.